Skip to content

Abemaciclib

Published: July 26, 2026Updated: August 26, 2026

Verzenio (abemaciclib) is a prescription medication classified as a CDK4/6 inhibitor used in the treatment of certain types of breast cancer. It is typically prescribed for adults with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer, either in combination with hormone therapy or as a standalone treatment.

Quick summary

Verzenio is a targeted cancer therapy that inhibits cell cycle progression and is used to treat certain types of advanced or metastatic breast cancer.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

RxNorm
1946831
Generic
Verzenio
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Verzenio is indicated for the treatment of HR+/HER2- advanced or metastatic breast cancer in combination with hormone therapy (such as an aromatase inhibitor or fulvestrant), or as monotherapy for disease progression following hormone therapy in postmenopausal women.

Verzenio inhibits cyclin-dependent kinases 4 and 6 (CDK4/6), which are enzymes that promote cell division and cancer growth. By blocking these kinases, the medication helps slow the progression of cancer cells through the cell cycle.

Common side effects include diarrhea, fatigue, nausea, and low blood cell counts. Regular blood monitoring is typically required during treatment. Verzenio may cause fetal harm and should not be used during pregnancy. It should only be prescribed by healthcare providers experienced in cancer therapy.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy